State of Wisconsin Investment Board
ADMS

State of Wisconsin Investment Board’s Adamas Pharmaceuticals ADMS Stock Holding History

State of Wisconsin Investment Board’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-34,200
Closed -$130K – 1756
2019
Q4 		$130K Hold
34,200
– – ﹤0.01% 1599
2019
Q3 		$175K Buy
34,200
+4,000
+13% +$24.7K ﹤0.01% 1511
2019
Q2 		$187K Buy
30,200
+700
+2% +$4.03K ﹤0.01% 1489
2019
Q1 		$210K Buy
29,500
+6,800
+30% +$61.1K ﹤0.01% 1459
2018
Q4 		$194K Buy
22,700
+100
+0.4% +$1.3K ﹤0.01% 1457
2018
Q3 		$452K Buy
22,600
+11,600
+105% +$272K ﹤0.01% 1419
2018
Q2 		$284K Hold
11,000
– – ﹤0.01% 1403
2018
Q1 		$263K Hold
11,000
– – ﹤0.01% 1380
2017
Q4 		$373K Hold
11,000
– – ﹤0.01% 1328
2017
Q3 		$233K Sell
11,000
-100,000
-90% -$1.83M ﹤0.01% 1389
2017
Q2 		$1.94M Buy
111,000
+11,000
+11% +$182K 0.01% 956
2017
Q1 		$1.75M Buy
+100,000
New +$1.7M 0.01% 926

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State of Wisconsin Investment Board's ADMS Position: Q1 2020 in Review

State of Wisconsin Investment Board sold out of Adamas Pharmaceuticals (ADMS) in Q1 2020, closing a stake of 34,200 shares — an estimated $130K sold.

State of Wisconsin Investment Board first reported a position in ADMS in Q1 2017 and held it in 12 quarters. The position peaked at $1.94M in Q2 2017. 73 funds tracked by Wall St. Rank hold ADMS as of Q1 2020.

  • State of Wisconsin Investment Board reported no remaining Adamas Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 34,200 Adamas Pharmaceuticals shares in Q1 2020, an estimated $130K.
  • State of Wisconsin Investment Board first reported a position in Adamas Pharmaceuticals in Q1 2017 and held it in 12 quarters.
  • State of Wisconsin Investment Board's Adamas Pharmaceuticals position peaked at $1.94M in Q2 2017.
  • 73 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2020, filed 6 May 2020.